237 filings
Page 8 of 12
8-K
GRI
GRI Bio Inc
10 Jun 22
Submission of Matters to a Vote of Security Holders
8:30am
EFFECT
GRI
GRI Bio Inc
9 Jun 22
Notice of effectiveness
12:15am
424B3
GRI
GRI Bio Inc
8 Jun 22
Prospectus supplement
4:43pm
DEF 14A
GRI
GRI Bio Inc
Definitive proxy
6 Jun 22
5:12pm
CORRESP
GRI
GRI Bio Inc
6 Jun 22
Correspondence with SEC
12:00am
UPLOAD
GRI
GRI Bio Inc
3 Jun 22
Letter from SEC
12:00am
S-1
GRI
GRI Bio Inc
IPO registration
27 May 22
5:23pm
PRE 14A
GRI
GRI Bio Inc
25 May 22
Preliminary proxy
11:58am
SC 13G
Lind Global Fund II LP
23 May 22
Vallon Pharmaceuticals / Lind Global Fund II ownership change
5:00pm
SC 13G
GRI
GRI Bio Inc
23 May 22
Vallon Pharmaceuticals / BIGGER CAPITAL FUND L P ownership change
4:30pm
8-K
GRI
GRI Bio Inc
18 May 22
Unregistered Sales of Equity Securities
5:07pm
SC 13G
GRI
GRI Bio Inc
18 May 22
Vallon Pharmaceuticals / Lincoln Park Capital Fund ownership change
12:34pm
8-K
GRI
GRI Bio Inc
13 May 22
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
5:12pm
424B5
GRI
GRI Bio Inc
13 May 22
Prospectus supplement for primary offering
5:08pm
8-K
GRI
GRI Bio Inc
12 May 22
Vallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR
8:37am
8-K
GRI
GRI Bio Inc
9 May 22
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:08pm
10-Q
2022 Q1
GRI
GRI Bio Inc
Quarterly report
9 May 22
12:00am
EFFECT
GRI
GRI Bio Inc
3 May 22
Notice of effectiveness
12:15am
424B3
GRI
GRI Bio Inc
2 May 22
Prospectus supplement
4:41pm
CORRESP
GRI
GRI Bio Inc
28 Apr 22
Correspondence with SEC
12:00am